MMP2 and malignant peripheral nerve sheath tumor: The experimental upregulation of miR-29c in MPNST cells resulted in reduced MMP2 activity, decreased invasion, and impaired metastatic potential, highlighting its potential as a therapeutic agent to control MPNST aggressiveness [49].